Koios Medical
Private Company
Total funding raised: $18M
Overview
Koios Medical is a private, commercial-stage diagnostics company founded in 2014 and headquartered in Buffalo, New York. The company has developed a proprietary AI/ML software platform, Koios DS™, which provides real-time decision support for radiologists interpreting breast and thyroid ultrasound scans, aiming to improve cancer detection rates and standardize diagnoses. With regulatory clearances in the US and EU, the company is actively deploying its software globally, supported by strategic investment from entities like Mitsui & Co. Koios operates a B2B software-as-a-medical-device (SaMD) business model, generating revenue through its commercial products.
Technology Platform
Proprietary AI/ML algorithms trained on >500,000 pathology-linked ultrasound images for real-time clinical decision support in breast and thyroid lesion classification. Cloud-based, vendor-agnostic software (Smart Ultrasound®) that integrates with existing ultrasound systems.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
The competitive landscape is crowded and includes pure-play AI radiology companies (e.g., Aidoc, Zebra Medical Vision), large imaging equipment manufacturers (GE, Siemens, Philips) integrating AI into their platforms, and other specialized ultrasound AI startups. Koios's differentiation lies in its specific FDA-first status for breast ultrasound AI, its large proprietary dataset, and its focus on seamless workflow integration.